QR-Code

Efficacy of XELOX plus Bevacizumab in Brain Metastasis from Rectal Cancer

Brain metastasis (BM) is rare in colorectal cancer (CRC) patients. Although BM from CRC is a late-stage phenomenon with an extremely poor prognosis, some subsets of patients would benefit from a multidisciplinary management strategy. The prognosis of patients with BM from CRC was associated with the...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Yoichiro Yoshida, Seiichiro Hoshino, Naoya Aisu, Masayasu Naito, Syu Tanimura, Takamitsu Sasaki, Shinsuke Takeno, Yuichi Yamashita
Format: Artigo
Sprache:Inglês
Veröffentlicht: Karger Publishers 2014-02-01
Schriftenreihe:Case Reports in Oncology
Schlagworte:
Chemotherapy
Brain metastasis
Bevacizumab
XELOX
Colorectal cancer
Online-Zugang:http://www.karger.com/Article/FullText/360132
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge